MAPT and Alzheimer disease: These data revealed the participation of NME8 (rs2718058) genetic variants in delayed cognitive decline, the elevated tau levels in CSF, the hippocampus atrophy, occipital gyrus atrophy, lateral ventricle hypometabolism throughout the AD physiopathological process.